LSNE Contract Manufacturing (now part of PCI Pharma Services)
Bedford, NH (acquired by PCI Pharma Services in 2021; formerly headquartered in Bedford, New Hampshire)
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (10)
○ EMA GMP
○ MHRA GMP
Quick Facts: LSNE Contract Manufacturing (now part of PCI Pharma Services)
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Bedford, NH (acquired by PCI Pharma Services in 2021; formerly headquartered in Bedford, New Hampshire)
- Modalities
- Sterile Fill-Finish (aseptic), Lyophilization, Biologics Injectables, Process Development, Lyophilization Cycle Development, Clinical Trial Material Manufacturing, Commercial Manufacturing
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About LSNE Contract Manufacturing (now part of PCI Pharma Services)
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesSterile Fill-Finish (aseptic), Lyophilization, Biologics Injectables, Process Development, Lyophilization Cycle Development, Clinical Trial Material Manufacturing, Commercial Manufacturing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (7 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press10 articles
Broad modality coverage (7 modalities)
Recent News 10 articles
PCI Pharma Services makes $1B investment to scale injectable manufacturing, device assembly - megaproject.com
PCI, on CDMO growth journey, nets 'sizable' investment from private equity heavyweights - Fierce Pharma
PCI Pharma Services completes acquisition of Ajinomoto Althea - Pharmaceutical Technology
CDMOs Roll Out Expansions for Parenteral Drugs - DCAT Value Chain Insights
PCI Pharma Services Receives Strategic Investment from Bain Capital, Kohlberg and Mubadala - Contract Pharma
Bain Capital expects PCI to benefit from nearshoring dynamics in biopharma - pehub.com
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities - Business Wire
PCI Pharma Services Expands U.S. Sterile Manufacturing and Drug-Device Capabilities in $1B+ Global Investment Program - citybiz
Private equity firms back PCI Pharma in bet on drug production - BioPharma Dive
An integrated path: how CDMOs are reshaping complex drug development - Manufacturing Chemist
Frequently Asked Questions About LSNE Contract Manufacturing (now part of PCI Pharma Services)
What is LSNE Contract Manufacturing (now part of PCI Pharma Services)'s CDMO Signal Score?
LSNE Contract Manufacturing (now part of PCI Pharma Services) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating LSNE Contract Manufacturing (now part of PCI Pharma Services) for a manufacturing program?
Use the free AI matchmaker to compare LSNE Contract Manufacturing (now part of PCI Pharma Services) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Pyramid Pharma Services (Pyramid Laboratories, Inc.)
Costa Mesa, CA
Biologics, Sterile Injectables / Aseptic Fill-Finish, Lyophilization, Peptides, Small Molecules, siRNA/Oligonucleotide Injectable, Formulation Development, Analytical & Stability Testing
PCI Pharma Services
Philadelphia, PA
Sterile fill-finish, Prefilled syringes, Cartridges, Vials, Lyophilization, ADC fill-finish, HPAPI, mRNA, Biologics, Oligonucleotides, Peptides
Argonaut Manufacturing Services
Carlsbad, CA
Aseptic Fill/Finish, Biologics (injectable), mAbs, Peptides, Small Molecules, Vaccines, IVD/Diagnostics, Lyophilization
Vetter Pharma International GmbH
Ravensburg, Germany
Sterile Fill-Finish (syringes, vials, cartridges), Aseptic Injectable Manufacturing, Clinical Manufacturing, Commercial Filling, Drug Product Development, Assembly & Secondary Packaging, Prefilled Drug-Delivery Systems, Oligonucleotides (fill-finish), Monoclonal Antibodies (fill-finish), Biologics Injectables
Bora Pharmaceuticals
Taipei, Taiwan
Small Molecule (Oral Solid Dose), Biologics (Drug Substance & Drug Product), Monoclonal Antibody, Sterile Injectables / Aseptic Fill-Finish, Semi-Solids (creams, ointments, gels), Liquids (solutions, suspensions, ophthalmics, nasal sprays), Lyophilization